2-Ethylbenzenethiol | CAS:4500-58-7

We serve 2-Ethylbenzenethiol CAS:4500-58-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Ethylbenzenethiol

Chemical Name:2-Ethylbenzenethiol
CAS.NO:4500-58-7
Synonyms:2-Ethylbenzenethiol
2-Ethylthiophol
o-ethylthiophenol
2-ETHYL MERCAPTOPHENOL
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 210.7±9.0 °C at 760 mmHg
Molecular Formula C8H10S
Molecular Weight 138.230
Flash Point 80.6±0.0 °C
 
Specification:
Appearance:Light yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like 2-Ethylbenzenethiol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-ETHYL MERCAPTOPHENOL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Ethylbenzenethiol Use and application,2-Ethylthiophol technical grade,usp/ep/jp grade.


Related News: Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one manufacturer The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.2,3-Dichloro-5-nitropyridine vendor “Ways to protect yourself against a potential animal source would be to avoid unnecessary contact with live animals and make sure that you wash your hands thoroughly after contact with an animal,” she adds.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.